A research team led by scientists at The University of Texas Medical School at Houston has determined the structure of an enzyme that, when defective, causes hereditary coproporphyria.
UT Clinic operated with the City of Houston has treated more than 6,000 evacuees.
A $5 million, 5-year program project grant to simulate brain function has been awarded to the UT-Houston Medical School Department of Neurobiology and Anatomy by the National Institute of Neurological Disorders and Strokes.
Hazim J. Safi, M.D., has been appointed the chairman designate of the new department of cardiothoracic and vascular surgery being created at The University of Texas-Houston Medical School.
Research at The Univeristy of Texas-Houston Medical School is heading out of this world. NASA's Space Shuttle launch slated for April 16 will lift off with UT-Houston's brain research onboard.
Heart disease causes nearly half of deaths and disability in Americans between the ages of 35 and 64. In fact, twenty to forty percent of middle aged people have early or advanced coronary disease, most without knowing it. But this deadly disease can be prevented or reversed without surgery, if detected, thanks to the pioneering efforts of K. Lance Gould, M.D., a cardiovascular specialist at the University of Texas-Houston Medical School.
The Environmental Protection Agency has awarded The University of Texas-Houston School of Public Health a $874,195 grant to determine whether exposure to an ingredient found in Agent Orange during the Vietnam War can be associated with neural tube defects in the veterans' children.
A hepatitis A vaccine, already approved for use in adults, is also proving to be effective and safe for infants, according to a researcher at The University of Texas-Houston School of Public Health.
Research at The University of Texas-Houston Health Science Center may help reduce the estimated 1.6 million deaths attributed each year to the malaria parasite Plasmodium falciparum.
The University of Texas-Houston has been awarded $2.5 million by the National Institute of Arthritis and Musculoskeletal and Skin Diseases to establish a Specialized Center of Research (SCOR) in scleroderma, a chronic, often fatal connective tissue disease. Headquartered in the UT-Houston Medical School division of rheumatology and clinical immuno-genetics, the center will conduct a wide range of investigations into the disease for which there is no known effective treatment or means of prevention.
Scientists at The University of Texas-Houston Medical School and the University of Alberta in Canada have determined the three-dimensional structure of cardiac troponin C (cardiac TnC), a protein responsible for regulating muscle contraction in the heart.
Adolescents who have been exposed to community violence are more likely to engage in violent behavior themselves, according to the results of a study presented by Jennifer Conroy M.P.H. of UT-Houston School of Public Health at the Annual Meeting of the Society of Behavioral Medicine (April 1997).
Neuroscientists at The University of Texas-Houston Health Science Center are a step closer to understanding the processes underlying learning and memory. In a report in the February 28 issue of Science magazine they describe how a protein molecule, transforming growth factor-fl (TGF-fl), induces changes in neurons similar to those associated with learning. This work may have implications for the treatment of learning disabilities in people whose nervous systems have been compromised by disease, injury or aging.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right